Cited by 1,229Atherosclerosis and Cardiovascular DiseasesLipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research

The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.

Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men

Ridker, Paul M, Hennekens, Charles H, Roitman-Johnson, Beatrice, Stampfer, Meir J, Allen, Jean·1998·The Lancet

DOI 10.1016/s0140-6736(97)09032-6

Open this paper in CoChat — free account

Abstract

Background The intercellular adhesion molecule ICAM-1 mediates adhesion and transmigration of leucocytes to the vascular endothelial wall, a step proposed to be critical in the initiation and progression of atherosclerosis. Whether concentrations of soluble ICAM-1 (sICAM-1) are raised in apparently healthy individuals who later suffer acute myocardial infarction is unknown.Methods We obtained baseline plasma samples from a prospective cohort of 14,916 healthy men enrolled in the Physicians' Health Study. With a nested case-control design, we measured sICAM-1 concentrations for 474 participants who developed a first myocardial infarction, and 474 controls (participants who remained healthy throughout the 9-year follow-up). Cases were matched to controls according to age and smoking status at the time of myocardial infarction.Findings We found a significant association between increasing concentration of sICAM-1 and risk of future myocardial infarction (p = 0.003), especially among participants with baseline sICAM-1 concentrations in the highest quartile (> 260 ng/mL; relative risk 1.6 [95% Cl 1.1-2.4], p = 0.02). This association was present overall as well as among non-smokers, and persisted after control for lipid and non-lipid risk factors. In multivariate analyses, the risk of future myocardial infarction was 80% higher for participants with baseline sICAM-1 concentrations in the highest quartile (relative risk 1.8 [1.1-2.8], p = 0.02). Similar risk estimates were seen among non-smokers. We found slight but significant correlations between sICAM-1 and fibrinogen, high-density-lipoprotein cholesterol, homocysteine, triglycerides, tissue-type plasminogen-activator antigen, and C-relative protein, but adjustment for these altered the risk little. The risk of myocardial infarction associated with raised concentrations of sICAM-1 seemed to increase with length of follow-up.Interpretation Our data support the hypothesis that cellular mediators of inflammation have a role in atherogenesis and provide a clinical basis to consider antiadhesion therapies as a novel means of cardiovascular disease prevention.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(97)09032-6

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,618
Adhesion receptors of the immune system
Springer, T. A. (1990) · Nature · doi:10.1038/346425a0 · Cited by 6,477
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1).
Dustin, M. L., Rothlein, R., Bhan, A. K., Dinarello, C. A., & Springer, T. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.1.245 · Cited by 2,450
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,267
Molecular Bases of the Acute Coronary Syndromes
Libby, P. (1995) · Circulation · doi:10.1161/01.cir.91.11.2844 · Cited by 2,029
Endothelial Expression of a Mononuclear Leukocyte Adhesion Molecule During Atherogenesis
Cybulsky, M. I., & Gimbrone, M. A. (1991) · Science · doi:10.1126/science.1990440 · Cited by 1,710
Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon.
Pober, J. S., Gimbrone, M. A., Lapierre, L. A., Mendrick, D. L., Fiers, W., Rothlein, R., & Springer, T. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.6.1893 · Cited by 1,413
The expression of the adhesion molecules ICAM‐1, VCAM‐1, PECAM, and E‐selectin in human atherosclerosis
Davies, M. J., Gordon, J. L., Gearing, A. J. H., Pigott, R., Woolf, N., Katz, D. R., & Kyriakopoulos, A. (1993) · The Journal of Pathology · doi:10.1002/path.1711710311 · Cited by 777
Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells
Pigott, R., Dillon, L. P., Hemingway, I., & Gearing, A. J. H. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91234-h · Cited by 650

Show all 35 references

Sorted by citations

Items 101–200 of 999

C-REACTIVE PROTEIN, INFLAMMATION, AND CORONARY RISK
Morrow, D. A., & Ridker, P. M. (2000) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70211-x · Cited by 216
“In concert with laboratory data, prospective clinical studies have evaluated several acute-phase proteins, cytokines, and intercellular adhesion molecules as potential novel markers for cardiovascular risk assessment [55–59].”
Background
C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular disease
Ridker, P. M. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.119214 · Cited by 206
Self-citation
Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians
Weyer, C., Yudkin, J. S., Stehouwer, C. D. A., Schalkwijk, C. G., Pratley, R. E., & Tataranni, P. A. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00626-8 · Cited by 214
A prospective evaluation of lipoprotein-associated phospholipase A2levels and the risk of future cardiovascular events in women
Blake, G. J., Dada, N., Fox, J. C., Manson, J. E., & Ridker, P. M. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01554-6 · Cited by 208
Inflammatory and Atherosclerotic Interactions in the Depleted Uremic Patient
Stenvinkel, P. (2000) · Blood Purification · doi:10.1159/000014479 · Cited by 207
The degree of unsaturation of dietary fatty acids and the development of atherosclerosis (review)
Moreno, J. J., & Mitjavila, M. T. (2003) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(02)00294-2 · Cited by 207
“Thus, soluble adhesion molecules levels represent a molecular marker of atherosclerosis and predict future myocardial infarction [147].”
Background
Inflammation and Atherothrombosis
Libby, P., & Ridker, P. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.011 · Cited by 204
Should Nonalcoholic Fatty Liver Disease Be Included in the Definition of Metabolic Syndrome?
Musso, G., Gambino, R., Bo, S., Uberti, B., Biroli, G., Pagano, G., & Cassader, M. (2008) · Diabetes Care · doi:10.2337/dc07-1526 · Cited by 197
Inflammatory biomarkers for predicting cardiovascular disease
Stoner, L. R., Lucero, A. A., Palmer, B. R., Jones, L. M., Young, J. M., & Faulkner, J. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.05.070 · Cited by 196
“provides similar predictive information to CRP in settings of primary prevention [126].”
Background
Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients
Ascer, E., Bertolami, M. C., Venturinelli, M. L., Buccheri, V., Souza, J. A., Nicolau, J. C., Ramires, J. A. F., & Junior, C. V. S. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.07.003 · Cited by 194
Circulating levels of ICAM‐1, VCAM‐1, and MCP‐1 are increased in haemodialysis patients: association with inflammation, dyslipidaemia, and vascular events
Papagianni, A. A., Alexopoulos, E., Giamalis, P., Gionanlis, L., Belechri, A., Koukoudis, P., & Memmos, D. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.3.435 · Cited by 197
Markers of Endothelial and Hemostatic Activation and Progression of Cerebral White Matter Hyperintensities: Longitudinal Results of the Austrian Stroke Prevention Study
Markus, H. S., Hunt, B., Palmer, K., Enzinger, C., Schmidt, H., & Schmidt, R. (2005) · Stroke · doi:10.1161/01.str.0000169924.60783.d4 · Cited by 193
Inflammation and Atherosclerosis
Jialal, I., & Devaraj, S. (2001) · Pathology Patterns Reviews · doi:10.1309/j63v-5lth-wyfc-vdr5 · Cited by 195
Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart disease: The PRIME Study
Luc, G., Arveiler, D., Evans, A., Amouyel, P., Ferrières, J., Bard, J., Elkhalil, L., Fruchart, J., & Ducimetière, P. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00280-6 · Cited by 193
“In the present study as in others [18,20], the association between ICAM-1 and CHD remained significant although this association disappeared in one of them [19] after adjustment for classical risk factors.”
BackgroundResult
C-reactive protein, inflammation, and coronary risk
Ridker, P. M., & Morrow, D. A. (2003) · Cardiology Clinics · doi:10.1016/s0733-8651(03)00079-1 · Cited by 192
Vascular inflammation: a role in vascular disease in hypertension?
Virdis, A., & Schiffrin, E. L. (2003) · Current Opinion in Nephrology and Hypertension · doi:10.1097/00041552-200303000-00009 · Cited by 182
Classic and Novel Risk Factor Parameters in Women With a History of Preeclampsia
Sattar, N. A., Ramsay, J. E., Crawford, L., Cheyne, H., & Greer, I. A. (2003) · Hypertension · doi:10.1161/01.hyp.0000074428.11168.ee · Cited by 185
Markers of Inflammation and Cellular Adhesion Molecules in Relation to Insulin Resistance in Nondiabetic Elderly: The Rotterdam Study
Hak, A. E., Pols, H. A. P., Stehouwer, C. D. A., Meijer, J., Kiliaan, A. J., Albert Hofman, D., Breteler, M. M. B., & Witteman, J. C. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.9.4398 · Cited by 185
Endothelial and Platelet Activation in Acute Ischemic Stroke and Its Etiological Subtypes
Cherian, P., Hankey, G. J., Eikelboom, J. W., Thom, J., Baker, R. I., McQuillan, A., Staton, J. M., & Yi, Q. (2003) · Stroke · doi:10.1161/01.str.0000086466.32421.f4 · Cited by 181
Proatherosclerotic Mechanisms Involving Protein Kinase C in Diabetes and Insulin Resistance
Rask‐Madsen, C., & King, G. L. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000155325.41507.e0 · Cited by 176
Tumor Necrosis Factor-α-converting Enzyme (TACE/ADAM-17) Mediates the Ectodomain Cleavage of Intercellular Adhesion Molecule-1 (ICAM-1)
Tsakadze, N. L., Sithu, S. D., Sen, U., English, W., Murphy, G., & D’Souza, S. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510797200 · Cited by 178
Elevated serum levels of soluble adhesion molecules predict death in pre‐dialysis patients: association with malnutrition, inflammation, and cardiovascular disease
Stenvinkel, P., Lindholm, B., Heimbürger, M., & Heimbürger, O. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.10.1624 · Cited by 178
Inflammatory Mediators and Cell Adhesion Molecules as Indicators of Severity of Atherosclerosis
van der Meer, I. M., de Maat, M. P. M., Bots, M. L., Breteler, M. M. B., Meijer, J., Kiliaan, A. J., Albert Hofman, D., & Witteman, J. C. M. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000016249.96529.b8 · Cited by 175
A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women
Conen, D., Ridker, P. M., Everett, B. M., Tedrow, U. B., Rose, L. M., Cook, N. R., Buring, J. E., & Albert, C. M. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq146 · Cited by 177
Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes
Głowińska‐Olszewska, B., Urban, M., Peczyńska, J., & Florys, B. (2005) · Metabolism · doi:10.1016/j.metabol.2005.03.004 · Cited by 175
The key contribution of platelet and vascular arachidonic acid metabolism to the pathophysiology of atherothrombosis
Badimón, L., Vilahur, G., Rocca, B., & Patrono, C. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab003 · Cited by 182
Chemokines and Cardiovascular Risk
Aukrust, P., Halvorsen, B. L., Yndestad, A., Ueland, T., Øie, E., Otterdal, K., Gullestad, L. L., & Damås, J. K. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.161240 · Cited by 180
Cellular adhesion molecules on vascular smooth muscle cells
Braun, M. A. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00302-2 · Cited by 174
Effects of moderate-intensity exercise training on plasma biomarkers of inflammation and endothelial dysfunction in older patients with type 2 diabetes
Zoppini, G., Targher, G., Zamboni, C., Venturi, C., Cacciatori, V., Moghetti, P., & Muggeo, M. (2006) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.09.004 · Cited by 173
Mining literature for a comprehensive pathway analysis: A case study for retrieval of homocysteine related genes for genetic and epigenetic studies
Sharma, P., Senthilkumar, R., Brahmachari, V., Sundaramoorthy, E., Mahajan, A., Sharma, A., & Sengupta, S. (2006) · Lipids in Health and Disease · doi:10.1186/1476-511x-5-1 · Cited by 171
Established and emerging cardiovascular risk factors
Wood, D. A. (2001) · American Heart Journal · doi:10.1067/mhj.2001.109951 · Cited by 171
Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management
Zanger, D. R., Yang, B. K., Ardans, J. A., Waclawiw, M. A., Csákó, G., Wahl, L. M., & Cannon, R. O. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00952-9 · Cited by 168
Inflammation as a Therapeutic Target in Atherosclerosis
Nguyen, M. T., Fernando, S., Schwarz, N., Tan, J. T. M., Bursill, C. A., & Psaltis, P. J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081109 · Cited by 176
Associations of Dietary Long-Chain n-3 Polyunsaturated Fatty Acids and Fish With Biomarkers of Inflammation and Endothelial Activation (from the Multi-Ethnic Study of Atherosclerosis [MESA])
He, K., Liu, K., Daviglus, M. L., Jenny, N. S., Mayer‐Davis, E. J., Jiang, R., Steffen, L. M., Siscovick, D. S., Tsai, M. Y., & Herrington, D. M. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.01.016 · Cited by 169
Inflammatory and endothelial markers in women with polycystic ovary syndrome
Diamanti‐Kandarakis, E., Alexandraki, K., Piperi, C., Protogerou, A. D., Katsikis, I., Paterakis, T., Lekakis, J., & Panidis, D. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01712.x · Cited by 168
Insulin Inhibits the Expression of Intercellular Adhesion Molecule-1 by Human Aortic Endothelial Cells through Stimulation of Nitric Oxide
Aljada, A., Saadeh, R., Assian, E., Ghanim, H., & Dandona, P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6677 · Cited by 180
Overexpression of Secretory Phospholipase A2 Causes Rapid Catabolism and Altered Tissue Uptake of High Density Lipoprotein Cholesteryl Ester and Apolipoprotein A-I*
Tietge, U., Maugeais, C., Cain, W. J., Grass, D., Glick, J., de Beer, F. D., & Rader, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10077 · Cited by 190
Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease mortality
Erikssen, G. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2148 · Cited by 164
Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus
Abbasi, F., Chu, J. W., McLaughlin, T., Lamendola, C. A., Leary, E. T., & Reaven, G. M. (2004) · Metabolism · doi:10.1016/j.metabol.2003.07.020 · Cited by 162
Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk
de Lemos, J. A., Hennekens, C. H., & Ridker, P. M. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00742-7 · Cited by 163
“Pathologic studies have demonstrated CAMs within and adjacent to atherosclerotic plaque (8–12), and clinical studies have suggested a role for CAMs in plaque disruption and subsequent acute coronary events (1,5,13,14).”
BackgroundResultInfluential
Plasma Adiponectin Levels and Five-Year Survival After First-Ever Ischemic Stroke
Efstathiou, S. P., Tsioulos, D. I., Tsiakou, A. G., Gratsias, Y. E., Pefanis, A. V., & Mountokalakis, T. D. (2005) · Stroke · doi:10.1161/01.str.0000177874.29849.f0 · Cited by 162
Psychoneuroimmunology of depression: clinical implications
Irwin, M. (2002) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2001.0654 · Cited by 160
Flow-Mediated Dilatation Is Impaired by a High–Saturated Fat Diet but Not by a High-Carbohydrate Diet
Keogh, J. B., Grieger, J. A., Noakes, M., & Clifton, P. M. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000163185.28245.a1 · Cited by 160
Novel Risk Factors for Atherosclerosis
Kullo, I. J., Gau, G. T., & Tajik, A. J. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.4.369 · Cited by 160
Inflammatory and thrombotic mechanisms in coronary atherosclerosis
Tousoulis, D., Davies, G., Stefanadis, C., Toutouzas, P., & Ambrose, J. A. (2003) · Heart · doi:10.1136/heart.89.9.993 · Cited by 159
Cross-Sectional Study of Soluble Intercellular Adhesion Molecule-1 and Cardiovascular Risk Factors in Apparently Healthy Men
Rohde, L. E. P., Hennekens, C. H., & Ridker, P. M. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.7.1595 · Cited by 159
Nitric Oxide, Atherosclerosis and the Clinical Relevance of Endothelial Dysfunction
Anderson, T. J. (2003) · Heart Failure Reviews · doi:10.1023/a:1022199021949 · Cited by 158
“Studies by Ridker have demonstrated a relationship with cardiovascular outcomes with interleukin-6 [199], TNF-α [200], soluble P selectin [22], and soluble ICAM-1 [21].”
Background
C-reactive protein: From innocent bystander to pivotal mediator of atherosclerosis
Labarrere, C. A., & Zaloga, G. P. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.03.039 · Cited by 158
Cardiovascular and metabolic abnormalities in the offspring of diabetic pregnancy
Manderson, J. G., Mullan, B. A., Patterson, C., Hadden, D. R., Traub, A. I., & McCance, D. R. (2002) · Diabetologia · doi:10.1007/s00125-002-0865-y · Cited by 153
Inflammation and Atherosclerosis
Kaperonis, E. A., Liapis, C. D., Kakisis, J. D., Dimitroulis, D., & Papavassiliou, V. G. (2005) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2005.11.001 · Cited by 155
The differential effects of metformin on markers of endothelial activation and inflammation in subjects with impaired glucose tolerance: A placebo-controlled, randomized clinical trial
Caballero, A. E., Delgado, A., Aguilar-Salinas, C. A., Herrera, A. N., Castillo, J. L., Cabrera, T., Gomez-Perez, F. J., & Rull, J. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0019 · Cited by 151
Type II diabetes mellitus and cardiovascular risk factors: Current therapeutic approaches.
Kalofoutis, C., Piperi, C., Kalofoutis, A., Harris, F., Phoenix, D. A., & Singh, J. (2007) · PubMed Central · Cited by 149
Plasma concentrations of VCAM‐1 and ICAM‐1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy
Clausen, P., Jacobsen, P. K., Rossing, K., Jensen, J. S., Parving, H. ‐., & Feldt‐Rasmussen, B. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00347.x · Cited by 150
Maternal diet influences DNA damage, aortic telomere length, oxidative stress, and antioxidant defense capacity in rats
Tarry‐Adkins, J. L., Martin‐Gronert, M. S., Chen, J. H., Cripps, R. L., & Ozanne, S. E. (2008) · The FASEB Journal · doi:10.1096/fj.07-099523 · Cited by 146
“ROS has also been implicated in the up-regulation of proinflammatory proteins such as soluble adhesion molecules (sAMs), which have been associated with various cardiovascular risk factors, including myocardial infarction ( 49 ).”
Background
Diabetes is a proinflammatory state: a translational perspective
Devaraj, S., Dasu, M. R. K., & Jialal, I. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.09.44 · Cited by 155
Malnutrition and Chronic Inflammation as Risk Factors for Cardiovascular Disease in Chronic Renal Failure
Stenvinkel, P. (2000) · Blood Purification · doi:10.1159/000046932 · Cited by 148
HIV infection, HAART, and endothelial adhesion molecules: current perspectives
Donati, K. D. G., Ricardo Rabagliati, B., Iacoviello, L., & Cauda, R. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)00971-5 · Cited by 147
Inflammation, Infection, and Cardiovascular Risk
Ridker, P. M. (1998) · Circulation · doi:10.1161/01.cir.97.17.1671 · Cited by 145
The Relationship Between Infection, Inflammation, and Cardiovascular Disease: An Overview
Lowe, G. D. O. (2001) · Annals of Periodontology · doi:10.1902/annals.2001.6.1.1 · Cited by 144
The relationship of soluble ICAM-1, VCAM-1, P-selectin and E-selectin to cardiovascular disease risk factors in healthy men and women
Demerath, E. W., Towne, B., Blangero, J., & Siervogel, R. M. (2001) · Annals of Human Biology · doi:10.1080/03014460110048530 · Cited by 144
“A relationship between sICAM-1 and smoking has been previously reported (Koudouros et al. 1996, Blann et al. 1997, Ridker et al. 1998), but the present study additionally demonstrated associations with sESEL and sPSEL, indicating a generalized in¯ammatory response to smoking.”
Result
Elevated plasma free fatty acids increase cardiovascular risk by inducing plasma biomarkers of endothelial activation, myeloperoxidase and PAI-1 in healthy subjects
Mathew, M., Tay, E., & Cusi, K. J. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-9 · Cited by 144
“Plasma measurement of cell adhesion molecules are accepted markers of endothelial dysfunction and vascular disease [9-16].”
Background
Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis
Speidl, W. S., Exner, M., Amighi, J., Kastl, S., Zorn, G., Maurer, G., Wagner, O. F., Huber, K., Minar, E., Wojta, J., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi339 · Cited by 143
Vascular Effects of Synthetic or Natural Progestagen Combined With Conjugated Equine Estrogen in Healthy Postmenopausal Women
Koh, K. K., Jin, D., Yang, S. H., Lee, S.-K., Hwang, H. Y., Kang, M. H., Kim, W. S., Kim, D. S., Choi, I. S., & Shin, E. K. (2001) · Circulation · doi:10.1161/01.cir.103.15.1961 · Cited by 142
Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells
Barter, P. J., Baker, P. W., & Rye, K. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200206000-00008 · Cited by 139
Inflammatory Markers in Men with Angiographically Documented Coronary Heart Disease
Rifai, N., Joubran, R., Yu, H., Asmi, M. H., & Jouma, M. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.11.1967 · Cited by 141
“An increased sICAM-1 concentration has been shown to be significantly associated with risk of future MI in men ( 15 ). In the latter study, sICAM-1 values in controls were ;30% lower, over a wide range of encountered concentrations, than those seen in our controls.”
BackgroundInfluential
Inflammation influences vascular remodeling through AT2receptor expression and signaling
Akishita, M., Horiuchi, M., Yamada, H., Zhang, L., Shirakami, G., Tamura, K., Ouchi, Y., & Dzau, V. J. (2000) · Physiological Genomics · doi:10.1152/physiolgenomics.2000.2.1.13 · Cited by 141
“Indeed, recent data have documented the pivotal role of inflammation in atherosclerosis and vascular diseases (23, 30, 31).”
Background
ENDOTHELIAL CELL ACTIVATION IN MEN WITH ERECTILE DYSFUNCTION WITHOUT CARDIOVASCULAR RISK FACTORS AND OVERT VASCULAR DAMAGE
Bocchio, M., Desideri, G., Scarpelli, P., Necozione, S., Properzi, G., Spartera, C., Francavilla, F., Ferri, C., & Francavilla, S. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000116325.06572.85 · Cited by 138
Acute and chronic stress induced changes in sensitivity of peripheral inflammatory pathways to the signals of multiple stress systems – 2011 Curt Richter Award Winner
Rohleder, N. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.12.015 · Cited by 136
Cocoa Polyphenols and Inflammatory Markers of Cardiovascular Disease
Khan, N., Khymenets, O., Urpí-Sardà, M., Tulipani, S., Garcia‐Aloy, M., Monagas, M., Cubillos, L. X. M., Llorach, R., & Andrés‐Lacueva, C. (2014) · Nutrients · doi:10.3390/nu6020844 · Cited by 142
“The differences in the circulating levels of cell adhesion molecules may reveal a stage for pathophysiological events due to activation or damage to various cells [204–206].”
Breaking up the tie: Disintegrin-like metalloproteinases as regulators of cell migration in inflammation and invasion
Reiß, K., Ludwig, A., & Säftig, P. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.02.009 · Cited by 136
Plasma cytokine response during the postprandial period: a potential causal process in vascular disease?
Burdge, G. C., & Calder, P. C. (2005) · British Journal Of Nutrition · doi:10.1079/bjn20041282 · Cited by 136
“Raised concentrations of soluble adhesion molecules are associated with increased CVD risk (Hwang et al. 1997; Morisaki et al. 1997; Ridker et al. 1998; Rohde et al. 1998) and are thought to reflect damage to the vascular endothelium.”
Background
Screening for atherosclerosis in patients with rheumatoid arthritis: Comparison of two in vivo tests of vascular function
Doornum, S. V., McColl, G., Jenkins, A. J., GREEN, D. J., & Wicks, I. P. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10735 · Cited by 138
Morning Levels of C-Reactive Protein in Children with Obstructive Sleep-disordered Breathing
Kaditis, A. G., Alexopoulos, E. Ι., Kalampouka, E., Kostadima, E., Germenis, A. E., Zintzaras, E., & Gourgoulianis, K. I. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200407-928oc · Cited by 134
“These findings together with the increased production of reactive oxygen species by monocytes and granulocytes exposed to recurrent hypoxia (39) indicate that sleep-disordered breathing promotes vascular inflammation and atherosclerosis (40, 41 ).”
Background
Von Willebrand Factor, Type 2 Diabetes Mellitus, and Risk of Cardiovascular Disease
Frankel, D. S., Meigs, J. B., Massaro, J. M., Wilson, P. W. F., O’Donnell, C. J., D’Agostino, R. B., & Tofler, G. H. (2008) · Circulation · doi:10.1161/circulationaha.108.792986 · Cited by 134
Endothelial dysfunctions: common denominators in vascular disease
Caterina, R. D. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200002000-00003 · Cited by 131
Role of inflammatory biomarkers in prediction of coronary heart disease
Ridker, P. M. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06112-8 · Cited by 136
Nuclear Factor- B Suppressive and Inhibitor- B Stimulatory Effects of Troglitazone in Obese Patients with Type 2 Diabetes: Evidence of an Antiinflammatory Action?
Aljada, A., Garg, R., Ghanim, H., Mohanty, P., Hamouda, W., Assian, E., & Dandona, P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7564 · Cited by 146
The U.S. Environmental Protection Agency Particulate Matter Health Effects Research Centers Program: a midcourse report of status, progress, and plans.
Lippmann, M., Frampton, M. W., Schwartz, J. D., Dockery, D. W., Schlesinger, R., Koutrakis, P., Froines, J. R., Nel, A. E., Finkelstein, J., Godleski, J. J., et al. (2003) · Environmental Health Perspectives · doi:10.1289/ehp.5750 · Cited by 131
Inflammation and atherosclerosis in rheumatoid arthritis
Stevens, R. J., Douglas, K., Saratzis, A. N., & Kitas, G. D. (2005) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399405009154 · Cited by 131
Effects of cardiopulmonary bypass on leukocyte and endothelial adhesion molecules
Asimakopoulos, G., & Taylor, K. M. (1998) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(98)00727-9 · Cited by 173
Effect of vitamin E on human aortic endothelial cell production of chemokines and adhesion to monocytes
Wu, D., Koga, T., Martin, K. R., & Meydani, M. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00199-9 · Cited by 127
“[35] Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J.”
Background
Nonalcoholic steatohepatitis versus steatosis: adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism
Musso, G., Cassader, M., De Michieli, F., Rosina, F., Orlandi, F., & Gambino, R. (2012) · Hepatology · doi:10.1002/hep.25739 · Cited by 126
Microalbuminuria and Endothelial Dysfunction: Emerging Targets for Primary Prevention of End-organ Damage
Ochodnický, P., Henning, R. H., van Dokkum, R. P. E., & de Zeeuw, D. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200606001-00009 · Cited by 126
Tumor Necrosis Factor Receptor Levels Are Associated With Carotid Atherosclerosis
Elkind, M. S. V., Cheng, J., Boden-Albala, B. M., Rundek, T., Thomas, J. A., Chen, H., Rabbani, L. E., & Sacco, R. L. (2002) · Stroke · doi:10.1161/hs0102.100531 · Cited by 126
Risk stratification in unstable angina and non-Q wave myocardial infarction using soluble cell adhesion molecules
Mulvihill, N. T., Foley, J. B., Murphy, R. T., Curtin, R., Crean, P., & Walsh, M. (2001) · Heart · doi:10.1136/heart.85.6.623 · Cited by 126
Serum carotenoids and vitamins in relation to markers of endothelial
Broekmans, W. M. R., Klöpping-Ketelaars, I. A. A., Bots, M. L., Kluft, C., Princen, H. M. G., Hendriks, F. J. H., Tijburg, L. B. M., van Poppel, G., & Kardinaal, A. F. M. (2004) · European Journal of Epidemiology · doi:10.1007/s10654-004-5760-z · Cited by 125
“[31] healthy subjects at baseline in the highest quartile of sICAM-1 (>260 ng/ml) had 80% higher risk of myocardial infarction in comparison with subjects in the lowest quartile (<193 ng/ml).”
Background
Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients
Muhlestein, J. B. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-03-0177 · Cited by 125
Elevated Soluble Cellular Adhesion Molecules in Subjects With Low HDL-Cholesterol
Calabresi, L., Gomaraschi, M., Villa, B., Omoboni, L., Dmitrieff, C., & Franceschini, G. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0402.105901 · Cited by 125
Genome-wide association with select biomarker traits in the Framingham Heart Study
Benjamin, E. J., Dupuis, J., Larson, M. G., Lunetta, K. L., Booth, S. L., Govindaraju, D. R., Kathiresan, S., Keaney, J. F., Keyes, M. J., Lin, J., et al. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-s1-s11 · Cited by 124
“For instance, the inflammatory marker C-reactive protein (CRP) predicts incident stroke [9], coronary heart disease [ 10-12 ], and all-cause mortality [13].”
Fluvastatin Reduces Soluble P-Selectin and ICAM-1 Levels in Hypercholesterolemic Patients: Role of Nitric Oxide
Romano, M., Mezzetti, A., Marulli, C., Ciabattoni, G., Febo, F., Ienno, S. D., Roccaforte, S., Vigneri, S., Nubile, G., Milani, M., et al. (2000) · Journal of Investigative Medicine · doi:10.1177/108155890004800305 · Cited by 125
Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study
Zakai, N. A., Katz, R., Jenny, N. S., Psaty, B. M., Reiner, A. P., SCHWARTZ, S. M., & Cushman, M. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02528.x · Cited by 127
Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus
Westerweel, P. E., Luyten, R. K. M. A. C., Koomans, H. A., Derksen, R. H. W. M., & Verhaar, M. C. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22568 · Cited by 124
Sudden Cardiac Death, Genes, and Arrhythmogenesis
Spooner, P. M., Albert, C. M., Benjamin, E. J., Boineau, R., Elston, R. C., George, A. L., Jouven, X., Kuller, L. H., MacCluer, J. W., Marbán, E., et al. (2001) · Circulation · doi:10.1161/01.cir.103.19.2361 · Cited by 122
Beneficial effects of polyphenol-rich olive oil in patients with early atherosclerosis
Widmer, R. J., Freund, M. A., Flammer, A. J., Sexton, J. M., Lennon, R. J., Romani, A., Mulinacci, N., Vinceri, F. F., Lerman, L. O., & Lerman, A. (2012) · European Journal of Nutrition · doi:10.1007/s00394-012-0433-2 · Cited by 122
“function as soon as 2 h after consumption [22]; however, the mechanism for this improvement and the responsible”
Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells
Hernández-Presa, M. Á., Martı́n-Ventura, J. L., Ortego, M., Gómez‐Hernández, A., Tuñón, J., Hernández-Vargas, P., Blanco‐Colio, L. M., Mas, S., Aparicio, C., Ortega, L. M., et al. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00547-0 · Cited by 122
Involvement of ICAM-1 in the progression of atherosclerosis in APOE-knockout mice
Kitagawa, K., Matsumoto, M., Sasaki, T., Hashimoto, H., Kuwabara, K., Ohtsuki, T., & Hori, M. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00587-1 · Cited by 121
ABO Blood Groups and Cardiovascular Diseases
Zhang, H., Mooney, C. J., & Reilly, M. P. (2012) · International Journal of Vascular Medicine · doi:10.1155/2012/641917 · Cited by 124
“Notably, mechanistic studies in rodent models have implicated these proteins in atherosclerosis [55– 59] and their blood levels in humans correlate with increased risk of CVD events [60, 61].”
Background
Reduced expression of endothelial cell markers after 1 year treatment with simvastatin and atorvastatin in patients with coronary heart disease
Seljeflot, I., Tonstad, S., Hjermann, I., & Arnesen, H. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00696-7 · Cited by 117
Intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 at the early stages of atherosclerosis in a rat model.
Fotis, L., Agrogiannis, G., Vlachos, I. S., Pantopoulou, A., Margoni, A., Kostaki, M., Verikokos, C., Tzivras, D. M., Mikhailidis, D. P., & Perrea, D. N. (2012) · PubMed · Cited by 120
Circulating ICAM-1 and VCAM-1 in Peripheral Artery Disease and Hypercholesterolaemia: Relationship to the Location of Atherosclerotic Disease, Smoking, and in the Prediction of Adverse Events
Seigneur, M., Steiner, M., Miller, J. P., McCollum, C. N., & Blann, A. D. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615019 · Cited by 119
“(36) reported that raised sICAM-1 is a strong risk factor for the development of myocardial infarction in apparently healthy men.”
Background

Authors: Ridker, P. M., Hennekens, C. H., Roitman-Johnson, B., Stampfer, M. J., & Allen, J.
Affiliations: Brigham and Women's Hospital (US)
R&D Systems (United States) (US)
Corresponding author: Ridker, Paul M
ORCID: Ridker, Paul M
Hennekens, Charles H
Stampfer, Meir J
Venue: The Lancet
Publisher: Elsevier BV
Published: 1998-01
Volume: 351
Issue: 9096
Pages: 88-92
ISSN: 0099-5355 (ISSN-L)
0140-6736
DOI: 10.1016/s0140-6736(97)09032-6
OpenAlex: W2138809584
Cited by: 1,229
References: 35
Citations by year: 2026: 7 · 2025: 10 · 2024: 8 · 2023: 10 · 2022: 16 · 2021: 16 · 2020: 17 · 2019: 23 · 2018: 14 · 2017: 28 · 2016: 27 · 2015: 25 · 2014: 38 · 2013: 27 · 2012: 36
FWCI: 26.16
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
Keywords: soluble intercellular adhesion molecule-1, sICAM-1, myocardial infarction, atherosclerosis, inflammation, endothelial cell adhesion, anti-adhesion therapy, cardiovascular risk, fibrinogen, homocysteine, tissue plasminogen activator, C-reactive protein, healthy men, Physicians' Health Study
MeSH terms: Antioxidants, Arteriosclerosis, Aspirin, Double-Blind Method, Humans, Male, Middle Aged, Myocardial Infarction, Platelet Aggregation Inhibitors, Prospective Studies, Risk Factors, Multivariate Analysis, Case-Control Studies, Intercellular Adhesion Molecule-1, beta Carotene

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks